Department of Cardiology and Cardiovascular Research, Shanghai Chest Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200030, P.R. China.
Int J Mol Med. 2013 Jul;32(1):144-50. doi: 10.3892/ijmm.2013.1355. Epub 2013 Apr 22.
Atrial fibrillation (AF) represents the most common form of sustained cardiac arrhythmia and accounts for substantial morbidity and mortality. Mutations in the cardiac sodium channel α, β1, β2 and β3 subunit genes (SCN5A, SCN1B, SCN2B and SCN3B) have been associated with AF, which suggests that mutations in the sodium channel β4 subunit gene, SCN4B, are also involved in the pathogenesis of AF. To examine this hypothesis, the coding exons and exon-intron boundaries of SCN4B were sequenced in 170 unrelated index patients with familial AF. The available relatives of the probands carrying the identified mutations and 200 unrelated ethnically matched healthy individuals used as the controls were subsequently genotyped. The pathogenic potential of a SCN4B sequence variation was predicted using MutationTaster. As a result, 2 novel heterozygous SCN4B mutations, p.V162G and p.I166L, were identified in 2 unrelated families with AF transmitted in an autosomal dominant pattern, respectively. In each family the mutation co-segregated with AF and was absent in the 400 control chromosomes. The mutations altered the amino acids evolutionarily highly conserved across species and were both predicted to be disease-causing. To the best of our knowledge, this is the first study to demonstrate an association of SCN4B mutations with AF, suggesting SCN4B as a novel AF susceptibility gene.
心房颤动 (AF) 是最常见的持续性心律失常,会导致较高的发病率和死亡率。心脏钠离子通道 α、β1、β2 和 β3 亚基基因 (SCN5A、SCN1B、SCN2B 和 SCN3B) 的突变与 AF 有关,这表明钠离子通道β4 亚基基因 SCN4B 的突变也参与了 AF 的发病机制。为了检验这一假说,我们对 170 名无血缘关系的家族性 AF 索引患者的 SCN4B 编码外显子和外显子-内含子边界进行了测序。随后对携带已鉴定突变的先证者的可利用亲属以及 200 名无血缘关系的、种族匹配的健康个体进行了基因分型。使用 MutationTaster 预测 SCN4B 序列变异的致病潜能。结果,在两个分别以常染色体显性遗传方式传递的 AF 相关的无血缘关系的家族中,发现了 2 种新的杂合 SCN4B 突变,p.V162G 和 p.I166L。在每个家族中,该突变与 AF 共分离,且在 400 个对照染色体中不存在。这些突变改变了跨物种高度保守的氨基酸,且均被预测为致病突变。据我们所知,这是首次证明 SCN4B 突变与 AF 相关的研究,表明 SCN4B 是一种新的 AF 易感基因。